123 related articles for article (PubMed ID: 17153907)
21. Lung parenchymal invasion in pulmonary carcinoid tumor: an important histologic feature suggesting the diagnosis of atypical carcinoid and poor prognosis.
Ha SY; Lee JJ; Cho J; Hyeon J; Han J; Kim HK
Lung Cancer; 2013 May; 80(2):146-52. PubMed ID: 23384672
[TBL] [Abstract][Full Text] [Related]
22. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
23. Atypical presentation of an atypical carcinoid.
Van Brandt V; Heyman S; Van Marck E; Hendriks J; Van Schil P
Ann Thorac Surg; 2009 Dec; 88(6):2004-6. PubMed ID: 19932277
[TBL] [Abstract][Full Text] [Related]
24. Carcinomas of the lung with neuroendocrine differentiation.
Carter D; Yesner R
Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
[TBL] [Abstract][Full Text] [Related]
25. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
[TBL] [Abstract][Full Text] [Related]
26. Bronchopulmonary neuroendocrine tumors.
Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine neoplasms of the lung. A clinicopathologic update.
Warren WH; Faber LP; Gould VE
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):321-32. PubMed ID: 2549306
[TBL] [Abstract][Full Text] [Related]
28. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification.
Mezzetti M; Raveglia F; Panigalli T; Giuliani L; Lo Giudice F; Meda S; Conforti S
Ann Thorac Surg; 2003 Dec; 76(6):1838-42. PubMed ID: 14667595
[TBL] [Abstract][Full Text] [Related]
29. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy.
Bogart JA; Aronowitz JN
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5004s-5010s. PubMed ID: 16000604
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients.
Zhong CX; Yao F; Zhao H; Shi JX; Fan LM
Chin Med J (Engl); 2012 Sep; 125(17):3022-6. PubMed ID: 22932173
[TBL] [Abstract][Full Text] [Related]
31. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
32. Bronchial carcinoid tumours in children: surgical treatment and outcome in a single institution.
Rizzardi G; Marulli G; Calabrese F; Rugge M; Rebusso A; Sartori F; Rea F
Eur J Pediatr Surg; 2009 Aug; 19(4):228-31. PubMed ID: 19513967
[TBL] [Abstract][Full Text] [Related]
33. Long-term clinical experience of high-dose ablative lung radiotherapy: high pre-treatment [18F]fluorodeoxyglucose-positron emission tomography maximal standardized uptake value of the primary tumor adversely affects treatment outcome.
Lee DS; Kim YS; Yoo IeR; Kang YN; Kim SJ; Oh JK; Kim YK; Wang YP; Park JG; Kang JH; Han DH; Ahn MI; Lee KY
Lung Cancer; 2013 May; 80(2):172-8. PubMed ID: 23489556
[TBL] [Abstract][Full Text] [Related]
34. The molecular pathogenesis and management of bronchial carcinoids.
Cakir M; Grossman A
Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
[TBL] [Abstract][Full Text] [Related]
35. Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: implications for radiation target volume design.
Olszyna-Serementa M; Socha J; Wierzchowski M; Kępka L
Lung Cancer; 2013 May; 80(2):179-84. PubMed ID: 23395416
[TBL] [Abstract][Full Text] [Related]
36. Ten-year adjuvant treatment with somatostatin analogs in a patient with atypical carcinoid of the lung.
Buonerba C; Gallo C; Di Lorenzo G; Romeo V; Marinelli A
Anticancer Drugs; 2010 Apr; 21(4):465-8. PubMed ID: 20075713
[TBL] [Abstract][Full Text] [Related]
37. [Carcinoid tumor of the larynx].
Mani R; Belcadhi M; Chahed H; Ben Abdelkader A; Bouzouita K
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):71-4. PubMed ID: 19268278
[TBL] [Abstract][Full Text] [Related]
38. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
Warren WH; Gould VE; Faber LP; Kittle CF; Memoli VA
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):819-25. PubMed ID: 2582209
[TBL] [Abstract][Full Text] [Related]
40. A twenty-five-year follow-up of ninety-three resected typical carcinoid tumors of the lung.
Schreurs AJ; Westermann CJ; van den Bosch JM; Vanderschueren RG; Brutel de la Rivière A; Knaepen PJ
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1470-5. PubMed ID: 1434731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
